Alzheimer’s blood biomarkers not ready for primary care use, expert panel decides
By
Alicia Lasek
Aug 18, 2022
An international group of clinicians and researchers have agreed that Alzheimer’s disease blood biomarkers are a significant breakthrough, but are not yet ready for general clinical and primary care...
Variant-adapted COVID shot approved in U.K.; Novavax requests U.S. booster nod
By
Alicia Lasek
Aug 16, 2022
Novavax wants its U.S. vaccine authorization to extend to a booster shot, and the U.K. has approved a two-component vaccine that directly tackles the omicron variant.
Hip fracture readmissions lower when nursing home in sync with hospital staff: study
By
Alicia Lasek
Apr 14, 2022
A collaboration between nursing home staff and hospital clinicians helped reduce readmission and mortality rates and improved quality of life for residents with hip fracture.
CMS restricts coverage of Alzheimer’s drug Aduhelm to clinical trials
By
Alicia Lasek
Apr 08, 2022
Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...
AHCA/NCAL: When inspected during pandemic, most nursing homes deficiency-free
By
Alicia Lasek
Mar 28, 2022
Despite navigating unprecedented hardship and loss during the pandemic, there is evidence that care in nursing homes held steady in a number of quantifiable areas, according to the organization’s...
Clinical briefs for Monday, March 21
By
Alicia Lasek
Mar 21, 2022
Aerosolized hydrogen peroxide slashes C. diff rates in acute-care settings … Memory deficits afflict about 70% of patients with long COVID, investigators say … Even with statins, high triglycerides...
Docs push for new COVID-19 funding as signs point to rebound in U.S. omicron cases
By
Alicia Lasek
Mar 17, 2022
The alternative is to risk leaving patients without access to needed vaccines, treatments and testing, the American College of Physicians has told Congress.
Pfizer, BioNTech to pursue 2nd booster shot authorization for older adults
By
Alicia Lasek
Mar 16, 2022
A second booster — or fourth dose — will be necessary to improve the vaccine’s waning protection in the face of omicron, Pfizer’s CEO has stated. Whether the FDA will find the evidence compelling...
Clinical briefs for Wednesday, March 9
By
Alicia Lasek
Mar 09, 2022
AHCA requests sit-down with Biden and top officials on nursing home reform plans … CDC director says COVID-19 will ‘probably’ become seasonal … Despite FDA efforts, fewer than 20% of drugs have...
Omicron sub-variants cut potency of monoclonal antibodies, mRNA vaccines: study
Mar 04, 2022
Eli Lilly’s bebtelovimab is the only authorized monoclonal antibody that can neutralize all three dominant sub-variants, investigators say.